Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 7526919, 7 pages
https://doi.org/10.1155/2017/7526919
Research Article

NGAL as an Early Predictive Marker of Diabetic Nephropathy in Children and Young Adults with Type 1 Diabetes Mellitus

1Department of Endocrinology, Department of Medical and Health Sciences, Linkoping University, Linkoping, Sweden
2Diabetes Centre, Department of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, National and Kapodistrian University of Athens, Aghia Sophia Children’s Hospital, Athens, Greece
3Department of Clinical Biochemistry, Aghia Sophia Children’s Hospital, Athens, Greece

Correspondence should be addressed to Nektaria Papadopoulou-Marketou; moc.liamg@airatkenuoluopodapap

Received 1 September 2016; Accepted 3 April 2017; Published 23 May 2017

Academic Editor: Feng Wang

Copyright © 2017 Nektaria Papadopoulou-Marketou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Nichols, S. Vupputuri, and H. Lau, “Medical care costs associated with progression of diabetic nephropathy,” Diabetes Care, vol. 34, no. 11, pp. 2374–2378, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. B. A. Perkins and A. S. Krolewski, “Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress,” Current Diabetes Reports, vol. 5, no. 6, pp. 455–463, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Raile, A. Galler, S. Hofer et al., “Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex,” Diabetes Care, vol. 30, no. 10, pp. 2523–2528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. L. M. Thorn, D. Gordin, V. Harjutsalo et al., “The presence and consequence of nonalbuminuric chronic kidney disease in patients with type 1 diabetes,” Diabetes Care, vol. 38, no. 11, pp. 2128–2133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Papadopoulou-Marketou, G. P. Chrousos, and C. Kanaka-Gantenbein, “Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis,” Diabetes/Metabolism Research and Reviews, vol. 33, no. 2, article e2841, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. C. E. Mogensen, “How to protect the kidney in diabetic patients: with special reference to IDDM,” Diabetes, vol. 46, Supplement 2, pp. S104–S111, 1997. View at Publisher · View at Google Scholar
  7. C. J. Schultz, T. Konopelska-Bahu, R. N. Dalton et al., “Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group,” Diabetes Care, vol. 22, no. 3, pp. 495–502, 1999. View at Publisher · View at Google Scholar
  8. B. A. Perkins, L. H. Ficociello, K. H. Silva, D. M. Finkelstein, J. H. Warram, and A. S. Krolewski, “Regression of microalbuminuria in type 1 diabetes,” The New England Journal of Medicine, vol. 348, no. 23, pp. 2285–2293, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. O. Access, “Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT),” BMC Pediatrics, vol. 9, p. 79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Lacquaniti, V. Donato, B. Pintaudi et al., ““Normoalbuminuric” diabetic nephropathy: tubular damage and NGAL,” Acta Diabetologica, vol. 50, no. 6, pp. 935–942, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Hovind, P. Rossing, L. Tarnow, R. J. Johnson, and H. H. Parving, “Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study,” Diabetes, vol. 58, no. 7, pp. 1668–1671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. J. Orchard, K. Y. Forrest, L. H. Kuller, and D. J. Becker, “Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study,” Diabetes Care, vol. 24, no. 6, pp. 1053–1059, 2001. View at Publisher · View at Google Scholar
  13. P. L. Poulsen, K. W. Hansen, and C. E. Mogensen, “Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients,” Diabetes, vol. 43, no. 10, pp. 1248–1253, 1994. View at Publisher · View at Google Scholar
  14. R. E. Gilbert and M. E. Cooper, “The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?” Kidney International, vol. 56, no. 5, pp. 1627–1637, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Steinke, A. R. Sinaiko, M. S. Kramer, S. Suissa, B. M. Chavers, and M. Mauer, “The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients,” Diabetes, vol. 54, no. 7, pp. 2164–2171, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. E. N. Ellis, B. A. Warady, E. G. Wood et al., “Renal structural-functional relationships in early diabetes mellitus,” Pediatric Nephrology (Berlin, Germany), vol. 11, no. 5, pp. 584–591, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. T. B. Torbjörnsdotter, N. E. S. S. Perrin, G. A. Jaremko, and U. B. Berg, “Widening of foot processes in normoalbuminuric adolescents with type 1 diabetes,” Pediatric Nephrology (Berlin, Germany), vol. 20, no. 6, pp. 750–758, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Papadopoulou-Marketou, C. Skevaki, I. Kosteria et al., “NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up,” Hormones (Athens, Greece), vol. 14, no. 2, pp. 232–240, 2015. View at Publisher · View at Google Scholar
  19. F. L. Nauta, W. E. Boertien, S. J. L. Bakker et al., “Glomerular and tubular damage markers are elevated in patients with diabetes,” Diabetes Care, vol. 34, no. 4, pp. 975–981, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. H. W. Chae, J. I. Shin, A. R. Kwon, H. S. Kim, and D. H. Kim, “Spot urine albumin to creatinine ratio and serum cystatin C are effective for detection of diabetic nephropathy in childhood diabetic patients,” Journal of Korean Medical Science, vol. 27, no. 7, pp. 784–787, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. K. M. Thrailkill, C. S. Moreau, G. E. Cockrell et al., “Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus,” Endocrine, vol. 37, no. 2, pp. 336–343, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. K. M. Schmidt-Ott, K. Mori, J. Y. Li et al., “Dual action of neutrophil gelatinase-associated lipocalin,” Journal of the American Society of Nephrology : JASN, vol. 18, no. 2, pp. 407–413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Haase, R. Bellomo, P. Devarajan, P. Schlattmann, A. Haase-Fielitz, and N. M. A. I. Grp, “Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis,” American Journal of Kidney Diseases, vol. 54, no. 6, pp. 1012–1024, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Haase-Fielitz, M. Haase, and P. Devarajan, “Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status,” Annals of Clinical Biochemistry, vol. 51, Part 3, pp. 335–351, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Haase, R. Bellomo, P. Devarajan et al., “Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults,” The Annals of Thoracic Surgery, vol. 88, no. 1, pp. 124–130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Hawkins, “New biomarkers of acute kidney injury and the cardio-renal syndrome,” The Korean Journal of Laboratory Medicine, vol. 31, no. 2, pp. 72–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Hyllienmark, N. Alstrand, B. Jonsson, J. Ludvigsson, G. Cooray, and J. Wahlberg-Topp, “Early electrophysiological abnormalities and clinical neuropathy: a prospective study in patients with type 1 diabetes,” Diabetes Care, vol. 36, no. 10, pp. 3187–3194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Grubb, M. Horio, L. O. Hansson et al., “Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator,” Clinical Chemistry, vol. 60, no. 7, pp. 974–986, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Uhlig and K. U. Eckardt, “A decade after the KDOQI CKD guidelines: impact on CKD guidelines,” American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation, vol. 60, no. 5, pp. 705-706, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. A. S. Krolewski, M. A. Niewczas, J. Skupien et al., “Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria,” Diabetes Care, vol. 37, no. 1, pp. 226–234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Eirin, M. L. Gloviczki, H. Tang et al., “Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin,” Nephrology, Dialysis, Transplantation, vol. 27, no. 11, pp. 4153–4161, 2012. View at Publisher · View at Google Scholar · View at Scopus